Hutch News

Hutch News

Stories tagged 'IIRC'

Learning more from T-cell therapy trials

Fred Hutch Immunotherapy Integrated Research Center awards grants to Drs. Brian Till, Cameron Turtle

March 28, 2018 | By Susan Keown / Fred Hutch News Service

Two Hutch teams have received new funding for in-depth study of the results emerging from ongoing trials of genetically engineered T-cell therapies.

View story >


New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer

Dec. 11, 2017 | By Fred Hutch staff

Detailed studies of two potential side effects of an emerging cancer immunotherapy could eventually help make this strategy, CAR T-cell therapy, safer for patients. The studies examined cytokine release syndrome and neurologic toxicities.

View story >


Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025

Sept. 26, 2017 | By Alan Boyle / GeekWire

Fred Hutch President and Director Gary Gilliland is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for “most, if not all, human cancers” by 2025.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.